Literature DB >> 12979063

Clinical use of the anticoagulant phenylindanedione; report of 74 cases.

F W PRESTON, W R O'CONNOR, C E THOMPSON, E N CHRISTENSEN.   

Abstract

Entities:  

Keywords:  PHENYLINDANEDIONE/dosage

Mesh：

Substances：

Year:  1952        PMID： 12979063     DOI： 10.1161/01.cir.6.4.515

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Clinical experience with phenylindanedione (danilone) with special reference to dosage.

Authors:  R E BEAMISH; S A CARTER
Journal:  Can Med Assoc J       Date:  1956-01-01       Impact factor: 8.262

2.  Severe sensitivity reaction (hepatitis, dermatitis and pyrexia) attributable to phenylindanedione.

Authors:  E N EAST; R E BEAMISH
Journal:  Can Med Assoc J       Date:  1957-12-01       Impact factor: 8.262

3.  Phenylindanedione: a useful anticoagulant.

Authors:  S R TOWNSEND; K J FAY; J R DOWNING; R LAING; D G CAMERON
Journal:  Can Med Assoc J       Date:  1953-08       Impact factor: 8.262

4.  The current status of the treatment of coronary heart disease.

Authors:  C K FRIEDBERG
Journal:  Can Med Assoc J       Date:  1953-02       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.